Targeted downregulation of TGF-beta2 as immunotherapy for high-grade glioma: A phase IIb study

Hau, P. and Kunst, M. and Pichler, J. and Parfenov, V. E. and Sastry, K. V. R. and Spitznagel, L. and Zaaroor, M. and Bogdahn, U. and Schlingensiepen, K. H. (2005) Targeted downregulation of TGF-beta2 as immunotherapy for high-grade glioma: A phase IIb study. In: 41st Annual Meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, Florida, USA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 14 Apr 2022 06:16
Last Modified: 14 Apr 2022 06:16
URI: https://pred.uni-regensburg.de/id/eprint/36059

Actions (login required)

View Item View Item